GLP Watchdog

Fridays vs Polly

Neither Fridays nor Polly has an FDA warning letter on record. On compounded tirzepatide injection, Polly costs $960 less a year at standing rates: $279 a month against $359 a month at Fridays. It is one of two products the two sell at comparable terms.

To see where both sit among the other sellers, read our best weight-loss injection providers board.

By Ruth Calder · Enforcement Editor
Editorially reviewed. Not medical advice · How we verify contentLast reviewed

The record

Fridays / Polly

Fridays logo

Fridays

5.8/10

Polly logo

Polly

8.4/10

FDA warning letters
None on record
None on record
Pharmacy
Lowest standing price
$249/moCompounded semaglutide injection
$179/moCompounded semaglutide injection
States
No state list published
All 50 states
Checked
Prices captured Record checked October 2026
Prices captured Record checked November 2026
Visit Fridays
Visit Polly

Neither Fridays nor Polly pays us. Links to them earn nothing. Scores: Fridays 5.8, Polly 8.4. How we are paid

What the record shows

  1. 01

    Neither Fridays nor Polly has an FDA warning letter on record.

  2. 02

    Fridays names four pharmacies. Polly names two pharmacies, all 503A.

  3. 03

    On compounded tirzepatide injection, Polly costs $960 less a year at standing rates: $279 a month against $359 a month at Fridays. It is one of two products the two sell at comparable terms.

  4. 04

    Only Fridays lists a price for brand-name semaglutide pen and brand-name tirzepatide pen.

  5. 05

    Polly lists all 50 states. Fridays publishes no state list.

  6. 06

    Fridays states you can cancel at any time; Polly does not state its cancellation terms.

Prices and terms, product by product

A price is set against the other side only for the same product, and only when both are standing monthly or 4-week rates. Those pairs are compared by yearly cost.

Fridays

Polly

Compounded semaglutide injection

$249/mo

$2,988 a year

$179/moLower

$2,148 a year

Compounded tirzepatide injection

$359/mo

$4,308 a year

$279/moLower

$3,348 a year

Brand-name semaglutide pen

$1,498/mo

$17,976 a year

Not sold or not priced
Brand-name tirzepatide pen

$1,828/mo

$21,936 a year

Not sold or not priced
Price includes
Medication, clinician visits, coaching
Medication, clinician visits, shipping
Cancel any time
Yes, stated
Not stated
Minimum term
None on the monthly plan; 3, 6 and 12-month plans are prepaid
Month to month, or a 3- or 6-month supply charged at checkout
Refunds
Fees are non-refundable except for medical disqualification, billing errors or where the law requires
Full refund only before the medical intake is submitted; 3- and 6-month plans cannot be refunded once the first month has passed
Early-exit fee
Not stated
Yes

Read off each seller’s own pages. Fridays: October 30, 2026. Polly: October 17, 2026. Every plan and dose we hold is on the full review.

The case for each

The case for Fridays

5.8/10
  • Sells brand-name semaglutide pen and brand-name tirzepatide pen, which Polly does not price
  • States you can cancel at any time
  • Publishes no state list
Visit Fridays

The case for Polly

8.4/10
  • $840 a year less on compounded semaglutide injection
  • $960 a year less on compounded tirzepatide injection
Visit Polly

Scores

Fridays 5.8 · Polly 8.4 out of 10. Six weighted parts.

Value25%

3.4A
vs
B
5.8

Effectiveness25%

10.0A
vs
B
10.0

User Experience15%

3.0A
vs
B
8.0

Trust & Safety15%

5.5A
vs
B
10.0

Accessibility10%

5.0A
vs
B
10.0

Support10%

7.0A
vs
B
7.0

The score is the same formula for every seller. Payment does not enter it. Method

Fridays vs Polly: questions

Neither Fridays nor Polly has an FDA warning letter on record. Letters are matched to a seller by company, domain and address, never by a similar name.
Fridays names four pharmacies. Polly names two pharmacies, all 503A. A 503A pharmacy compounds for named patients on a prescription; a 503B outsourcing facility is registered with FDA and inspected under federal manufacturing rules.
Polly, by $840 a year at standing rates. Fridays: $249 a month, about $2,988 a year. Polly: $179 a month, about $2,148 a year.
Fridays states you can cancel at any time; refunds: fees are non-refundable except for medical disqualification, billing errors or where the law requires. Polly does not state its cancellation terms.
Neither Fridays nor Polly pays us. Links to them earn nothing. Scores: Fridays 5.8, Polly 8.4.

Other sellers we are paid by

Affiliate partners outside this pair. Each has its own record and review, scored the same way.

Sellers closest to these two

Matched on molecule, form and price. Every pair we list · The register

Brand names on this page are registered marks. Novo Nordisk holds Wegovy®, Ozempic® and Rybelsus®; Eli Lilly holds Zepbound®, Mounjaro® and Foundayo®. Neither company has any tie to GLP Watchdog. Trademarks